Alnylam Pharmaceuticals Inc. has added another "first" to its list of accomplishments Monday when regulators approved its drug for a rare kidney disorder.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,